Literature DB >> 21334917

Clinical impact of visceral pleural, lymphovascular and perineural invasion in completely resected non-small cell lung cancer.

Aydin Yilmaz1, Sezgi Sahin Duyar, Ebru Cakir, Ertan Aydin, Funda Demirag, Jale Karakaya, Ulku Yazici, Yurdanur Erdogan.   

Abstract

OBJECTIVES: This study is conducted to show the relationship between visceral pleural, lymphovascular, and perineural invasion, and other clinicopathologic characteristics and their significance as prognostic factors.
METHODS: The clinicopathologic characteristics of 289 patients who underwent a potentially curative surgical resection between 2000 and 2009 in our clinic were reviewed retrospectively. The prognostic factors were then evaluated by univariate and multivariate analysis. The patients who were given neoadjuvant-adjuvant chemotherapy and/or radiotherapy and who died due to postoperative mortality were excluded. Data from 188 patients were analyzed.
RESULTS: Out of the 188 patients (108 diagnosed as adenocarcinoma and 80 squamous cell carcinoma), 66 patients had lymphovascular invasion, 53 patients had perineural invasion, and 92 patients had visceral pleural invasion. Visceral pleural invasion was related with T factor, tumor histology, dimension, stage, and differentiation. Lymphovascular invasion was related with N status and stage. Perineural invasion was observed more frequently in tumors with moderate/poor differentiation. Visceral pleural and lymphovascular invasion were found to be poor prognostic factors but we could not show statistically meaningful effect of perineural invasion on survival.
CONCLUSION: The presence of visceral pleural or lymphovascular invasion can show higher risk of mortality whereas perineural invasion has no effect on prognosis.
Copyright © 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21334917     DOI: 10.1016/j.ejcts.2010.12.059

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  20 in total

1.  Factors affecting tumor recurrence after curative surgery for NSCLC: impacts of lymphovascular invasion on early tumor recurrence.

Authors:  Chanyeong Park; In Jae Lee; Seung Hun Jang; Jae Woong Lee
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

2.  Refining Prognosis in Lung Cancer: A Report on the Quality and Relevance of Clinical Prognostic Tools.

Authors:  Alyson L Mahar; Carolyn Compton; Lisa M McShane; Susan Halabi; Hisao Asamura; Ramon Rami-Porta; Patti A Groome
Journal:  J Thorac Oncol       Date:  2015-11       Impact factor: 15.609

3.  Prognostic factors in non-small cell lung cancer patients who received neoadjuvant therapy and curative resection.

Authors:  Chen-Ping Hsieh; Ming-Ju Hsieh; Ching-Feng Wu; Jui-Ying Fu; Yun-Hen Liu; Yi-Cheng Wu; Cheng-Ta Yang; Ching-Yang Wu
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

Review 4.  Pulmonary adenocarcinoma: implications of the recent advances in molecular biology, treatment and the IASLC/ATS/ERS classification.

Authors:  Swaroop Revannasiddaiah; Priyanka Thakur; Bhaskar Bhardwaj; Sridhar Papaiah Susheela; Irappa Madabhavi
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

5.  Association between clinicopathological factors and postoperative radiotherapy in patients with completely resected pathological N2 non-small cell lung cancer.

Authors:  Yujin Xu; Jianqiang Li; Jin Wang; Xiao Hu; Honglian Ma; Pu Li; Xiao Zheng; Ming Chen
Journal:  Oncol Lett       Date:  2017-12-13       Impact factor: 2.967

Review 6.  Tumor progression: the neuronal input.

Authors:  Marco Arese; Federico Bussolino; Margherita Pergolizzi; Laura Bizzozero; Davide Pascal
Journal:  Ann Transl Med       Date:  2018-03

7.  Lymphatic vessel invasion in pathologic stage I and II non-small cell lung tumors.

Authors:  Hyun Woo Jeon; Kyung Soo Kim; Young-Du Kim; Keon Hyun Jo; Hyung Joo Park; Young Pil Wang; Jae Kil Park
Journal:  Surg Today       Date:  2014-11-26       Impact factor: 2.549

8.  Choice of the surgical approach for patients with stage I lung squamous cell carcinoma ≤3 cm.

Authors:  Chunji Chen; Yiyang Wang; Xufeng Pan; Shijie Fu; Yubo Shi; Jun Yang; Rui Wang
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

9.  Predicting the prognosis of lung cancer: the evolution of tumor, node and metastasis in the molecular age-challenges and opportunities.

Authors:  Ramón Rami-Porta; Hisao Asamura; Peter Goldstraw
Journal:  Transl Lung Cancer Res       Date:  2015-08

10.  A nomogram to predict overall survival of patients with early stage non-small cell lung cancer.

Authors:  Jiahui Zhang; Jingyi Fan; Rong Yin; Liguo Geng; Meng Zhu; Wei Shen; Yuzhuo Wang; Yang Cheng; Zhihua Li; Juncheng Dai; Guangfu Jin; Zhibin Hu; Hongxia Ma; Lin Xu; Hongbing Shen
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.